Literature DB >> 8592323

Familial amyotrophic lateral sclerosis/motor neurone disease (FALS): a review of current developments.

J de Belleroche1, R Orrell, A King.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8592323      PMCID： PMC1051731          DOI： 10.1136/jmg.32.11.841

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  54 in total

1.  Disruption of the CNTF gene results in motor neuron degeneration.

Authors:  Y Masu; E Wolf; B Holtmann; M Sendtner; G Brem; H Thoenen
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

Review 2.  Motor neurone disease.

Authors:  A Goonetilleke; J de Belleroche; R J Guiloff
Journal:  Essays Biochem       Date:  1994       Impact factor: 8.000

3.  Identification of two novel mutations and a new polymorphism in the gene for Cu/Zn superoxide dismutase in patients with amyotrophic lateral sclerosis.

Authors:  J Esteban; D R Rosen; A C Bowling; P Sapp; D McKenna-Yasek; J P O'Regan; M F Beal; H R Horvitz; R H Brown
Journal:  Hum Mol Genet       Date:  1994-06       Impact factor: 6.150

4.  More than one locus for familial amyotrophic lateral sclerosis: absence of linkage to the SMA locus.

Authors:  A W King; R W Orrell; R Lane; J S de Belleroche
Journal:  Biochem Soc Trans       Date:  1994-05       Impact factor: 5.407

5.  Superoxide dismutase and ALS.

Authors:  R W Orrell; J S deBelleroche
Journal:  Lancet       Date:  1994-12-17       Impact factor: 79.321

6.  Identification of a novel exon 4 SOD1 mutation in a sporadic amyotrophic lateral sclerosis patient.

Authors:  C T Jones; P J Shaw; G Chari; D J Brock
Journal:  Mol Cell Probes       Date:  1994-08       Impact factor: 2.365

7.  Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis.

Authors:  D A Figlewicz; A Krizus; M G Martinoli; V Meininger; M Dib; G A Rouleau; J P Julien
Journal:  Hum Mol Genet       Date:  1994-10       Impact factor: 6.150

8.  Familial amyotrophic lateral sclerosis (ALS) in Japan associated with H46R mutation in Cu/Zn superoxide dismutase gene: a possible new subtype of familial ALS.

Authors:  M Aoki; M Ogasawara; Y Matsubara; K Narisawa; S Nakamura; Y Itoyama; K Abe
Journal:  J Neurol Sci       Date:  1994-10       Impact factor: 3.181

9.  Analysis of the functional effects of a mutation in SOD1 associated with familial amyotrophic lateral sclerosis.

Authors:  T Tsuda; S Munthasser; P E Fraser; M E Percy; I Rainero; G Vaula; L Pinessi; L Bergamini; G Vignocchi; D R McLachlan
Journal:  Neuron       Date:  1994-09       Impact factor: 17.173

10.  A new variant Cu/Zn superoxide dismutase (Val7-->Glu) deduced from lymphocyte mRNA sequences from Japanese patients with familial amyotrophic lateral sclerosis.

Authors:  M Hirano; J Fujii; Y Nagai; M Sonobe; K Okamoto; H Araki; N Taniguchi; S Ueno
Journal:  Biochem Biophys Res Commun       Date:  1994-10-28       Impact factor: 3.575
View more
  15 in total

1.  A novel locus for familial amyotrophic lateral sclerosis, on chromosome 18q.

Authors:  Collette K Hand; Jawad Khoris; François Salachas; François Gros-Louis; Ana Amélia Simões Lopes; Veronique Mayeux-Portas; Carl G Brewer; Robert H Brown; Vincent Meininger; William Camu; Guy A Rouleau
Journal:  Am J Hum Genet       Date:  2001-11-09       Impact factor: 11.025

Review 2.  The Gordon Wilson Lecture. Decade of the brain: advances and hopes at the midpoint.

Authors:  G S Oxford
Journal:  Trans Am Clin Climatol Assoc       Date:  1997

Review 3.  Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases.

Authors:  Mahesh Ramalingam; Sung-Jin Kim
Journal:  J Neural Transm (Vienna)       Date:  2012-01-04       Impact factor: 3.575

Review 4.  Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis.

Authors:  H M Bryson; B Fulton; P Benfield
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

5.  Normal complement of motor units in asymptomatic familial (SOD1 mutation) amyotrophic lateral sclerosis carriers.

Authors:  A Aggarwal; G Nicholson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-10       Impact factor: 10.154

6.  Novel mutations in an otherwise strictly conserved domain of CuZn superoxide dismutase.

Authors:  R M Luche; R Maiwald; E J Carlson; C J Epstein
Journal:  Mol Cell Biochem       Date:  1997-03       Impact factor: 3.396

7.  Switch region for pathogenic structural change in conformational disease and its prediction.

Authors:  Xin Liu; Ya-Pu Zhao
Journal:  PLoS One       Date:  2010-01-11       Impact factor: 3.240

Review 8.  Strategic approaches to developing drug treatments for ALS.

Authors:  Andrea M Vincent; Stacey A Sakowski; Adam Schuyler; Eva L Feldman
Journal:  Drug Discov Today       Date:  2007-11-26       Impact factor: 7.851

9.  Phenotypic effects of familial amyotrophic lateral sclerosis mutant Sod alleles in transgenic Drosophila.

Authors:  Robin J Mockett; Svetlana N Radyuk; Judith J Benes; William C Orr; Rajindar S Sohal
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-26       Impact factor: 11.205

10.  Impact of presymptomatic genetic testing for familial amyotrophic lateral sclerosis.

Authors:  Joanna H Fanos; Susan Gronka; Joanne Wuu; Christine Stanislaw; Peter M Andersen; Michael Benatar
Journal:  Genet Med       Date:  2011-04       Impact factor: 8.822
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.